Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Willow Biosciencesinc (WLLW.TO)

Willow Biosciencesinc (WLLW.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 141,989
  • Shares Outstanding, K 123,469
  • Annual Sales, $ 10 K
  • Annual Income, $ -33,946 K
  • 60-Month Beta 1.46
  • Price/Sales 7,351.41
  • Price/Cash Flow N/A
  • Price/Book 6.18
Trade WLLW.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.49
  • Most Recent Earnings -0.10 on 03/31/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.10 +4.55%
on 05/19/21
1.30 -11.54%
on 05/17/21
-0.15 (-11.54%)
since 05/14/21
3-Month
1.05 +9.52%
on 05/12/21
1.85 -37.84%
on 03/19/21
-0.48 (-29.45%)
since 03/15/21
52-Week
0.29 +296.55%
on 06/17/20
2.24 -48.66%
on 02/11/21
+0.81 (+238.24%)
since 06/15/20

Most Recent Stories

More News
Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)

/PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF), a biotechnology company producing ultra-pure, sustainably made compounds, and Cellular Goods PLC ("") (LSE: CBX), a U.K....

WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
CBX.LN : 6.980 (-0.29%)
Willow Biosciences Announces Participation In Synbiobeta Panel Discussion

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Announces Annual General and Special Meeting Voting Results

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human Skin

, /PRNewswire/ -Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed a series of studies with its development partner, Signum Biosciences, Inc.,...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

VANCOUVER, BC, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first...

AMRI : 21.74 (unch)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of...

CANSF : 0.9600 (+2.54%)
WLLW.TO : 1.15 (+0.88%)
WLLW-WT.TO : 0.71 (+10.94%)
Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market

, /PRNewswire/ -Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol...

WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Provides Update on Cannabigerol Research Studies and Key Personnel Appointment

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it is undertaking two initiatives to help our customers evaluate and better understand...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)
Willow Biosciences Advances its Commericalization Plan; First Commercial Production Expected in Early 2021

"Advancing to commercial-scale production is the final step in our transition to becoming a revenue generating company," said , Willow's President and Chief Executive Officer. "Our ability to begin this...

CANSF : 0.9600 (+2.54%)
WLLW.TO : 1.15 (+0.88%)
Willow Biosciences Reports Third Quarter 2020 Results and Operational Update

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and nine months ended , reporting significant advancement...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 1.15 (+0.88%)
CANSF : 0.9600 (+2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 1.21
2nd Resistance Point 1.19
1st Resistance Point 1.17
Last Price 1.15
1st Support Level 1.13
2nd Support Level 1.11
3rd Support Level 1.09

See More

52-Week High 2.24
Fibonacci 61.8% 1.50
Fibonacci 50% 1.26
Last Price 1.15
Fibonacci 38.2% 1.03
52-Week Low 0.29

See More

Business Summary

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar